Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

sanofi-aventis
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 05/01/2011
PIL Suprefact Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 05/01/2011 and displayed until Current
Reasons for adding or updating:
  • Change to storage instructions
Updated on 01/12/2009 and displayed until 05/01/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Changes to therapeutic indications
Updated on 01/08/2008 and displayed until 01/12/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 16/08/2006 and displayed until 01/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 06/06/2003 and displayed until 16/08/2006
Reasons for adding or updating:
  • Update to PIL

Active Ingredients/Generics

 
  buserelin acetate